Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16686821
[patent_doc_number] => 20210069296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => TREATMENT OF PYROPTOSIS
[patent_app_type] => utility
[patent_app_number] => 17/026534
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026534 | Treatment of pyroptosis | Sep 20, 2020 | Issued |
Array
(
[id] => 16807851
[patent_doc_number] => 20210130404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 17/018751
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018751
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018751 | PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME | Sep 10, 2020 | Pending |
Array
(
[id] => 17815402
[patent_doc_number] => 11421001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Template-fixed peptidomimetics
[patent_app_type] => utility
[patent_app_number] => 17/013111
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6377
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013111
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013111 | Template-fixed peptidomimetics | Sep 3, 2020 | Issued |
Array
(
[id] => 18443589
[patent_doc_number] => 11679140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Prevention and/or treatment of hearing loss or impairment
[patent_app_type] => utility
[patent_app_number] => 16/940010
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 23
[patent_no_of_words] => 38637
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940010 | Prevention and/or treatment of hearing loss or impairment | Jul 26, 2020 | Issued |
Array
(
[id] => 16581533
[patent_doc_number] => 20210015935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => HEMOGLOBIN-BASED THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/947124
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947124
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947124 | Hemoglobin-based therapeutic agents | Jul 19, 2020 | Issued |
Array
(
[id] => 16569156
[patent_doc_number] => 20210008162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Peptides and Methods for Treating Disease
[patent_app_type] => utility
[patent_app_number] => 16/926782
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16926782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/926782 | Peptides and methods for treating disease | Jul 12, 2020 | Issued |
Array
(
[id] => 16569167
[patent_doc_number] => 20210008173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMORS, FIBROSIS AND ACUTE LUNG INJURY
[patent_app_type] => utility
[patent_app_number] => 16/919680
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919680 | ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMORS, FIBROSIS AND ACUTE LUNG INJURY | Jul 1, 2020 | Abandoned |
Array
(
[id] => 16359420
[patent_doc_number] => 20200316171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF GAUCHER DISEASE VIA MODULATION OF C5A RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/912756
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912756 | Methods and compositions for treatment of Gaucher Disease via modulation of C5a receptor | Jun 25, 2020 | Issued |
Array
(
[id] => 16969351
[patent_doc_number] => 11065298
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-07-20
[patent_title] => Compositions and methods for treating or preventing viral infections
[patent_app_type] => utility
[patent_app_number] => 16/896092
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6505
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896092 | Compositions and methods for treating or preventing viral infections | Jun 7, 2020 | Issued |
Array
(
[id] => 16581491
[patent_doc_number] => 20210015893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING ALCOHOLIC LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/887860
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887860 | Methods and compositions for treating alcoholic liver disease | May 28, 2020 | Issued |
Array
(
[id] => 17822685
[patent_doc_number] => 11427623
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-30
[patent_title] => Methods of treatment using mutant FGF-21 peptide conjugates
[patent_app_type] => utility
[patent_app_number] => 16/885353
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 126
[patent_no_of_words] => 23576
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885353 | Methods of treatment using mutant FGF-21 peptide conjugates | May 27, 2020 | Issued |
Array
(
[id] => 18217452
[patent_doc_number] => 11592382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Method of analyzing post-translational modifications
[patent_app_type] => utility
[patent_app_number] => 16/884367
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 57
[patent_no_of_words] => 17488
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884367 | Method of analyzing post-translational modifications | May 26, 2020 | Issued |
Array
(
[id] => 16437092
[patent_doc_number] => 20200354418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => HMGB1 ANTAGONIST TREATMENT OF ACUTE LUNG INJURY
[patent_app_type] => utility
[patent_app_number] => 16/869913
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869913 | HMGB1 antagonist treatment of acute lung injury | May 7, 2020 | Issued |
Array
(
[id] => 16252170
[patent_doc_number] => 20200261544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier
[patent_app_type] => utility
[patent_app_number] => 16/866764
[patent_app_country] => US
[patent_app_date] => 2020-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866764 | Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier | May 4, 2020 | Pending |
Array
(
[id] => 16398771
[patent_doc_number] => 20200339629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => THERAPEUTIC CONSTRUCTS COMPRISING CMET BINDING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/855292
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855292
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/855292 | THERAPEUTIC CONSTRUCTS COMPRISING CMET BINDING PEPTIDES | Apr 21, 2020 | Abandoned |
Array
(
[id] => 16204868
[patent_doc_number] => 20200237858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => DAPTOMYCIN FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/849387
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849387 | DAPTOMYCIN FORMULATIONS AND USES THEREOF | Apr 14, 2020 | Abandoned |
Array
(
[id] => 16343604
[patent_doc_number] => 20200308254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => CARTILAGE REPLACEMENT COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/833641
[patent_app_country] => US
[patent_app_date] => 2020-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833641 | Cartilage replacement compositions and methods | Mar 28, 2020 | Issued |
Array
(
[id] => 17921607
[patent_doc_number] => 11464828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Reconstituted HDL formulation
[patent_app_type] => utility
[patent_app_number] => 16/826585
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 6554
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826585
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826585 | Reconstituted HDL formulation | Mar 22, 2020 | Issued |
Array
(
[id] => 17726581
[patent_doc_number] => 11382946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Multi-functional peptides and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/823981
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3170
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823981 | Multi-functional peptides and use thereof | Mar 18, 2020 | Issued |
Array
(
[id] => 17576991
[patent_doc_number] => 20220133846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => NOVEL ANTIMICROBIAL COMPOUND AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/434254
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434254 | NOVEL ANTIMICROBIAL COMPOUND AND USES THEREOF | Mar 5, 2020 | Abandoned |